Medical Care
Global Extracorporeal Photopheresis (ECP) Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 580669
- Pages: 120
- Figures: 128
- Views: 7
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Extracorporeal Photopheresis (ECP) market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Haemonetics
Fresenius Kabi
Terumo
Macopharma
Mallinckrodt Pharmaceuticals
Med Tech Solutions
Segment by Type
Photopheresis Protocols
Photosensitizing Agents
Other
Segment by Application
Bronchiolitis Obliterans Syndrome (BOS)
Recurrent Acute Rejection
Other
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Extracorporeal Photopheresis (ECP) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Extracorporeal Photopheresis (ECP) market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Haemonetics
Fresenius Kabi
Terumo
Macopharma
Mallinckrodt Pharmaceuticals
Med Tech Solutions
Segment by Type
Photopheresis Protocols
Photosensitizing Agents
Other
Segment by Application
Bronchiolitis Obliterans Syndrome (BOS)
Recurrent Acute Rejection
Other
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Extracorporeal Photopheresis (ECP) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Extracorporeal Photopheresis (ECP): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Extracorporeal Photopheresis (ECP) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Photopheresis Protocols
1.2.3 Photosensitizing Agents
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Extracorporeal Photopheresis (ECP) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Bronchiolitis Obliterans Syndrome (BOS)
1.3.3 Recurrent Acute Rejection
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Extracorporeal Photopheresis (ECP) Revenue Estimates and Forecasts 2020-2031
2.2 Global Extracorporeal Photopheresis (ECP) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Extracorporeal Photopheresis (ECP) Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Extracorporeal Photopheresis (ECP) Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Photopheresis Protocols Market Size by Players
3.3.2 Photosensitizing Agents Market Size by Players
3.3.3 Other Market Size by Players
3.4 Global Extracorporeal Photopheresis (ECP) Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Extracorporeal Photopheresis (ECP) Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Extracorporeal Photopheresis (ECP) Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
6.4 North America Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Extracorporeal Photopheresis (ECP) Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
7.4 Europe Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Extracorporeal Photopheresis (ECP) Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
8.4 Asia-Pacific Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Extracorporeal Photopheresis (ECP) Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
9.4 Central and South America Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Extracorporeal Photopheresis (ECP) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
10.4 Middle East and Africa Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Extracorporeal Photopheresis (ECP) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Haemonetics
11.1.1 Haemonetics Corporation Information
11.1.2 Haemonetics Business Overview
11.1.3 Haemonetics Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.1.4 Haemonetics Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.1.5 Haemonetics Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.1.6 Haemonetics Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.1.7 Haemonetics Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.1.8 Haemonetics Extracorporeal Photopheresis (ECP) SWOT Analysis
11.1.9 Haemonetics Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Corporation Information
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.2.4 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.2.5 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.2.6 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.2.7 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.2.8 Fresenius Kabi Extracorporeal Photopheresis (ECP) SWOT Analysis
11.2.9 Fresenius Kabi Recent Developments
11.3 Terumo
11.3.1 Terumo Corporation Information
11.3.2 Terumo Business Overview
11.3.3 Terumo Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.3.4 Terumo Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.3.5 Terumo Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.3.6 Terumo Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.3.7 Terumo Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.3.8 Terumo Extracorporeal Photopheresis (ECP) SWOT Analysis
11.3.9 Terumo Recent Developments
11.4 Macopharma
11.4.1 Macopharma Corporation Information
11.4.2 Macopharma Business Overview
11.4.3 Macopharma Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.4.4 Macopharma Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.4.5 Macopharma Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.4.6 Macopharma Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.4.7 Macopharma Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.4.8 Macopharma Extracorporeal Photopheresis (ECP) SWOT Analysis
11.4.9 Macopharma Recent Developments
11.5 Mallinckrodt Pharmaceuticals
11.5.1 Mallinckrodt Pharmaceuticals Corporation Information
11.5.2 Mallinckrodt Pharmaceuticals Business Overview
11.5.3 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.5.4 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.5.5 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.5.6 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.5.7 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.5.8 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) SWOT Analysis
11.5.9 Mallinckrodt Pharmaceuticals Recent Developments
11.6 Med Tech Solutions
11.6.1 Med Tech Solutions Corporation Information
11.6.2 Med Tech Solutions Business Overview
11.6.3 Med Tech Solutions Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.6.4 Med Tech Solutions Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.6.5 Med Tech Solutions Recent Developments
12 Extracorporeal Photopheresis (ECP)Industry Chain Analysis
12.1 Extracorporeal Photopheresis (ECP) Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Extracorporeal Photopheresis (ECP) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Extracorporeal Photopheresis (ECP) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Extracorporeal Photopheresis (ECP): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Extracorporeal Photopheresis (ECP) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Photopheresis Protocols
1.2.3 Photosensitizing Agents
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Extracorporeal Photopheresis (ECP) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Bronchiolitis Obliterans Syndrome (BOS)
1.3.3 Recurrent Acute Rejection
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Extracorporeal Photopheresis (ECP) Revenue Estimates and Forecasts 2020-2031
2.2 Global Extracorporeal Photopheresis (ECP) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Extracorporeal Photopheresis (ECP) Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Extracorporeal Photopheresis (ECP) Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Photopheresis Protocols Market Size by Players
3.3.2 Photosensitizing Agents Market Size by Players
3.3.3 Other Market Size by Players
3.4 Global Extracorporeal Photopheresis (ECP) Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Extracorporeal Photopheresis (ECP) Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Extracorporeal Photopheresis (ECP) Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
6.4 North America Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Extracorporeal Photopheresis (ECP) Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
7.4 Europe Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Extracorporeal Photopheresis (ECP) Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
8.4 Asia-Pacific Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Extracorporeal Photopheresis (ECP) Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
9.4 Central and South America Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Extracorporeal Photopheresis (ECP) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Extracorporeal Photopheresis (ECP) Market Size by Type (2020-2031)
10.4 Middle East and Africa Extracorporeal Photopheresis (ECP) Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Extracorporeal Photopheresis (ECP) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Haemonetics
11.1.1 Haemonetics Corporation Information
11.1.2 Haemonetics Business Overview
11.1.3 Haemonetics Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.1.4 Haemonetics Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.1.5 Haemonetics Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.1.6 Haemonetics Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.1.7 Haemonetics Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.1.8 Haemonetics Extracorporeal Photopheresis (ECP) SWOT Analysis
11.1.9 Haemonetics Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Corporation Information
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.2.4 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.2.5 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.2.6 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.2.7 Fresenius Kabi Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.2.8 Fresenius Kabi Extracorporeal Photopheresis (ECP) SWOT Analysis
11.2.9 Fresenius Kabi Recent Developments
11.3 Terumo
11.3.1 Terumo Corporation Information
11.3.2 Terumo Business Overview
11.3.3 Terumo Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.3.4 Terumo Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.3.5 Terumo Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.3.6 Terumo Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.3.7 Terumo Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.3.8 Terumo Extracorporeal Photopheresis (ECP) SWOT Analysis
11.3.9 Terumo Recent Developments
11.4 Macopharma
11.4.1 Macopharma Corporation Information
11.4.2 Macopharma Business Overview
11.4.3 Macopharma Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.4.4 Macopharma Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.4.5 Macopharma Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.4.6 Macopharma Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.4.7 Macopharma Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.4.8 Macopharma Extracorporeal Photopheresis (ECP) SWOT Analysis
11.4.9 Macopharma Recent Developments
11.5 Mallinckrodt Pharmaceuticals
11.5.1 Mallinckrodt Pharmaceuticals Corporation Information
11.5.2 Mallinckrodt Pharmaceuticals Business Overview
11.5.3 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.5.4 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.5.5 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue by Product in 2024
11.5.6 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue by Application in 2024
11.5.7 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) Revenue by Geographic Area in 2024
11.5.8 Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) SWOT Analysis
11.5.9 Mallinckrodt Pharmaceuticals Recent Developments
11.6 Med Tech Solutions
11.6.1 Med Tech Solutions Corporation Information
11.6.2 Med Tech Solutions Business Overview
11.6.3 Med Tech Solutions Extracorporeal Photopheresis (ECP) Product Features and Attributes
11.6.4 Med Tech Solutions Extracorporeal Photopheresis (ECP) Revenue and Gross Margin (2020-2025)
11.6.5 Med Tech Solutions Recent Developments
12 Extracorporeal Photopheresis (ECP)Industry Chain Analysis
12.1 Extracorporeal Photopheresis (ECP) Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Extracorporeal Photopheresis (ECP) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Extracorporeal Photopheresis (ECP) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Extracorporeal Photopheresis (ECP) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Extracorporeal Photopheresis (ECP) Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Extracorporeal Photopheresis (ECP) Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Extracorporeal Photopheresis (ECP) by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracorporeal Photopheresis (ECP) as of 2024)
Table 11. Global Extracorporeal Photopheresis (ECP) Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Extracorporeal Photopheresis (ECP) Companies Headquarters
Table 13. Global Extracorporeal Photopheresis (ECP) Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Extracorporeal Photopheresis (ECP) Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Extracorporeal Photopheresis (ECP) Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Extracorporeal Photopheresis (ECP) Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Extracorporeal Photopheresis (ECP) Revenue by Application (2026-2031) & (US$ Million)
Table 21. Extracorporeal Photopheresis (ECP) High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Extracorporeal Photopheresis (ECP) Growth Accelerators and Market Barriers
Table 25. North America Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Extracorporeal Photopheresis (ECP) Growth Accelerators and Market Barriers
Table 27. Europe Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Extracorporeal Photopheresis (ECP) Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Extracorporeal Photopheresis (ECP) Investment Opportunities and Key Challenges
Table 31. Central and South America Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Extracorporeal Photopheresis (ECP) Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Haemonetics Corporation Information
Table 35. Haemonetics Description and Major Businesses
Table 36. Haemonetics Product Features and Attributes
Table 37. Haemonetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Haemonetics Revenue Proportion by Product in 2024
Table 39. Haemonetics Revenue Proportion by Application in 2024
Table 40. Haemonetics Revenue Proportion by Geographic Area in 2024
Table 41. Haemonetics Extracorporeal Photopheresis (ECP) SWOT Analysis
Table 42. Haemonetics Recent Developments
Table 43. Fresenius Kabi Corporation Information
Table 44. Fresenius Kabi Description and Major Businesses
Table 45. Fresenius Kabi Product Features and Attributes
Table 46. Fresenius Kabi Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Fresenius Kabi Revenue Proportion by Product in 2024
Table 48. Fresenius Kabi Revenue Proportion by Application in 2024
Table 49. Fresenius Kabi Revenue Proportion by Geographic Area in 2024
Table 50. Fresenius Kabi Extracorporeal Photopheresis (ECP) SWOT Analysis
Table 51. Fresenius Kabi Recent Developments
Table 52. Terumo Corporation Information
Table 53. Terumo Description and Major Businesses
Table 54. Terumo Product Features and Attributes
Table 55. Terumo Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Terumo Revenue Proportion by Product in 2024
Table 57. Terumo Revenue Proportion by Application in 2024
Table 58. Terumo Revenue Proportion by Geographic Area in 2024
Table 59. Terumo Extracorporeal Photopheresis (ECP) SWOT Analysis
Table 60. Terumo Recent Developments
Table 61. Macopharma Corporation Information
Table 62. Macopharma Description and Major Businesses
Table 63. Macopharma Product Features and Attributes
Table 64. Macopharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Macopharma Revenue Proportion by Product in 2024
Table 66. Macopharma Revenue Proportion by Application in 2024
Table 67. Macopharma Revenue Proportion by Geographic Area in 2024
Table 68. Macopharma Extracorporeal Photopheresis (ECP) SWOT Analysis
Table 69. Macopharma Recent Developments
Table 70. Mallinckrodt Pharmaceuticals Corporation Information
Table 71. Mallinckrodt Pharmaceuticals Description and Major Businesses
Table 72. Mallinckrodt Pharmaceuticals Product Features and Attributes
Table 73. Mallinckrodt Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Mallinckrodt Pharmaceuticals Revenue Proportion by Product in 2024
Table 75. Mallinckrodt Pharmaceuticals Revenue Proportion by Application in 2024
Table 76. Mallinckrodt Pharmaceuticals Revenue Proportion by Geographic Area in 2024
Table 77. Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) SWOT Analysis
Table 78. Mallinckrodt Pharmaceuticals Recent Developments
Table 79. Med Tech Solutions Corporation Information
Table 80. Med Tech Solutions Description and Major Businesses
Table 81. Med Tech Solutions Product Features and Attributes
Table 82. Med Tech Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Med Tech Solutions Recent Developments
Table 84. Raw Materials Key Suppliers
Table 85. Distributors List
Table 86. Market Trends and Market Evolution
Table 87. Market Drivers and Opportunities
Table 88. Market Challenges, Risks, and Restraints
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Extracorporeal Photopheresis (ECP) Product Picture
Figure 2. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Photopheresis Protocols Product Picture
Figure 4. Photosensitizing Agents Product Picture
Figure 5. Other Product Picture
Figure 6. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Bronchiolitis Obliterans Syndrome (BOS)
Figure 8. Recurrent Acute Rejection
Figure 9. Other
Figure 10. Extracorporeal Photopheresis (ECP) Report Years Considered
Figure 11. Global Extracorporeal Photopheresis (ECP) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 13. Global Extracorporeal Photopheresis (ECP) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Region (2020-2031)
Figure 15. Global Extracorporeal Photopheresis (ECP) Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Photopheresis Protocols Revenue Market Share by Player in 2024
Figure 18. Photosensitizing Agents Revenue Market Share by Player in 2024
Figure 19. Other Revenue Market Share by Player in 2024
Figure 20. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Type (2020-2031)
Figure 21. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Application (2020-2031)
Figure 22. North America Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
Figure 24. North America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
Figure 31. Europe Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 34. France Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 46. India Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
Figure 54. Central and South America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
Figure 60. South America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 66. Extracorporeal Photopheresis (ECP) Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Extracorporeal Photopheresis (ECP) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Extracorporeal Photopheresis (ECP) Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Extracorporeal Photopheresis (ECP) Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Extracorporeal Photopheresis (ECP) by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracorporeal Photopheresis (ECP) as of 2024)
Table 11. Global Extracorporeal Photopheresis (ECP) Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Extracorporeal Photopheresis (ECP) Companies Headquarters
Table 13. Global Extracorporeal Photopheresis (ECP) Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Extracorporeal Photopheresis (ECP) Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Extracorporeal Photopheresis (ECP) Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Extracorporeal Photopheresis (ECP) Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Extracorporeal Photopheresis (ECP) Revenue by Application (2026-2031) & (US$ Million)
Table 21. Extracorporeal Photopheresis (ECP) High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Extracorporeal Photopheresis (ECP) Growth Accelerators and Market Barriers
Table 25. North America Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Extracorporeal Photopheresis (ECP) Growth Accelerators and Market Barriers
Table 27. Europe Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Extracorporeal Photopheresis (ECP) Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Extracorporeal Photopheresis (ECP) Investment Opportunities and Key Challenges
Table 31. Central and South America Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Extracorporeal Photopheresis (ECP) Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Extracorporeal Photopheresis (ECP) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Haemonetics Corporation Information
Table 35. Haemonetics Description and Major Businesses
Table 36. Haemonetics Product Features and Attributes
Table 37. Haemonetics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Haemonetics Revenue Proportion by Product in 2024
Table 39. Haemonetics Revenue Proportion by Application in 2024
Table 40. Haemonetics Revenue Proportion by Geographic Area in 2024
Table 41. Haemonetics Extracorporeal Photopheresis (ECP) SWOT Analysis
Table 42. Haemonetics Recent Developments
Table 43. Fresenius Kabi Corporation Information
Table 44. Fresenius Kabi Description and Major Businesses
Table 45. Fresenius Kabi Product Features and Attributes
Table 46. Fresenius Kabi Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Fresenius Kabi Revenue Proportion by Product in 2024
Table 48. Fresenius Kabi Revenue Proportion by Application in 2024
Table 49. Fresenius Kabi Revenue Proportion by Geographic Area in 2024
Table 50. Fresenius Kabi Extracorporeal Photopheresis (ECP) SWOT Analysis
Table 51. Fresenius Kabi Recent Developments
Table 52. Terumo Corporation Information
Table 53. Terumo Description and Major Businesses
Table 54. Terumo Product Features and Attributes
Table 55. Terumo Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Terumo Revenue Proportion by Product in 2024
Table 57. Terumo Revenue Proportion by Application in 2024
Table 58. Terumo Revenue Proportion by Geographic Area in 2024
Table 59. Terumo Extracorporeal Photopheresis (ECP) SWOT Analysis
Table 60. Terumo Recent Developments
Table 61. Macopharma Corporation Information
Table 62. Macopharma Description and Major Businesses
Table 63. Macopharma Product Features and Attributes
Table 64. Macopharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Macopharma Revenue Proportion by Product in 2024
Table 66. Macopharma Revenue Proportion by Application in 2024
Table 67. Macopharma Revenue Proportion by Geographic Area in 2024
Table 68. Macopharma Extracorporeal Photopheresis (ECP) SWOT Analysis
Table 69. Macopharma Recent Developments
Table 70. Mallinckrodt Pharmaceuticals Corporation Information
Table 71. Mallinckrodt Pharmaceuticals Description and Major Businesses
Table 72. Mallinckrodt Pharmaceuticals Product Features and Attributes
Table 73. Mallinckrodt Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Mallinckrodt Pharmaceuticals Revenue Proportion by Product in 2024
Table 75. Mallinckrodt Pharmaceuticals Revenue Proportion by Application in 2024
Table 76. Mallinckrodt Pharmaceuticals Revenue Proportion by Geographic Area in 2024
Table 77. Mallinckrodt Pharmaceuticals Extracorporeal Photopheresis (ECP) SWOT Analysis
Table 78. Mallinckrodt Pharmaceuticals Recent Developments
Table 79. Med Tech Solutions Corporation Information
Table 80. Med Tech Solutions Description and Major Businesses
Table 81. Med Tech Solutions Product Features and Attributes
Table 82. Med Tech Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Med Tech Solutions Recent Developments
Table 84. Raw Materials Key Suppliers
Table 85. Distributors List
Table 86. Market Trends and Market Evolution
Table 87. Market Drivers and Opportunities
Table 88. Market Challenges, Risks, and Restraints
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Extracorporeal Photopheresis (ECP) Product Picture
Figure 2. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Photopheresis Protocols Product Picture
Figure 4. Photosensitizing Agents Product Picture
Figure 5. Other Product Picture
Figure 6. Global Extracorporeal Photopheresis (ECP) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Bronchiolitis Obliterans Syndrome (BOS)
Figure 8. Recurrent Acute Rejection
Figure 9. Other
Figure 10. Extracorporeal Photopheresis (ECP) Report Years Considered
Figure 11. Global Extracorporeal Photopheresis (ECP) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 13. Global Extracorporeal Photopheresis (ECP) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Region (2020-2031)
Figure 15. Global Extracorporeal Photopheresis (ECP) Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Photopheresis Protocols Revenue Market Share by Player in 2024
Figure 18. Photosensitizing Agents Revenue Market Share by Player in 2024
Figure 19. Other Revenue Market Share by Player in 2024
Figure 20. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Type (2020-2031)
Figure 21. Global Extracorporeal Photopheresis (ECP) Revenue Market Share by Application (2020-2031)
Figure 22. North America Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
Figure 24. North America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
Figure 31. Europe Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 34. France Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 46. India Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Extracorporeal Photopheresis (ECP) Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
Figure 54. Central and South America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Extracorporeal Photopheresis (ECP) Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Extracorporeal Photopheresis (ECP) Revenue (US$ Million) in 2024
Figure 60. South America Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Extracorporeal Photopheresis (ECP) Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Extracorporeal Photopheresis (ECP) Revenue (2020-2025) & (US$ Million)
Figure 66. Extracorporeal Photopheresis (ECP) Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232